{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:30:20Z","timestamp":1779312620350,"version":"3.51.4"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.rvsc.2021.02.011","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T02:45:56Z","timestamp":1613529956000},"page":"217-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31\/CpG-ODN\/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb\/c mice"],"prefix":"10.1016","volume":"135","author":[{"given":"Mar\u00eda Celeste","family":"Moran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel Ricardo","family":"Bence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Fernanda S\u00e1nchez","family":"Vallecillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Mar\u00eda","family":"L\u00fctzelschwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Gast\u00f3n","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Alberto","family":"Goldbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"Zylberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago Daniel","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belkys Ang\u00e9lica","family":"Maletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Marcela","family":"Estein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2021.02.011_bb0005","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1128\/IAI.69.8.4816-4822.2001","article-title":"Protection of BALB\/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant","volume":"69","author":"Al-Mariri","year":"2001","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.rvsc.2021.02.011_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060682","article-title":"The ocular conjunctiva as a mucosal immunization route: a profile of the immune response to the model antigen tetanus toxoid","volume":"8","author":"Barisani-Asenbauer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0015","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.176.4.2366","article-title":"A polymeric bacterial protein activates dendritic cells via TLR4","volume":"176","author":"Berguer","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0020","series-title":"Animal Brucellosis","first-page":"352","article-title":"Brucella ovis","author":"Blasco","year":"1990"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0025","first-page":"25","article-title":"Brucelosis ovina: epidemiolog\u00eda, patogenia y cuadro cl\u00ednico","volume":"8","author":"Blasco","year":"1990","journal-title":"Ovis."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0140-6736(93)91571-3","article-title":"Brucella melitensis rev 1 vaccine as a cause of human brucellosis","volume":"342","author":"Blasco","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0378-1135(87)90029-0","article-title":"Immunization with Brucella melitensis rev 1 against Brucella ovis infection of rams","volume":"14","author":"Blasco","year":"1987","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0165-2427(93)90198-D","article-title":"Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams","volume":"37","author":"Blasco","year":"1993","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4049\/jimmunol.1601775","article-title":"Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems","volume":"199","author":"Boyaka","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/00480169.1955.33172","article-title":"Observations on the transmission of Brucella infection in sheep","volume":"3","author":"Buddle","year":"1954","journal-title":"N. Z. Vet. J."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0055","first-page":"551","article-title":"Ovine contagious epididymitis: a review vet","volume":"7","author":"Burgess","year":"1982","journal-title":"Microbiol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0060","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/j.vaccine.2007.03.028","article-title":"A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination","volume":"25","author":"Cassataro","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02319","article-title":"Class-B CpG-ODN formulated with a nanostructure induces type I interferons-dependent and CD4+ T cell-independent CD8+ T-cell response against unconjugated protein antigen","volume":"9","author":"Chiodetti","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0070","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1016\/j.vaccine.2013.07.041","article-title":"The vaccine candidate BLSOmp31 protects mice against Brucella canis infection","volume":"31","author":"Clausse","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0075","series-title":"Brucelosis ovina y caprina. Vacunas y vacunaci\u00f3n","author":"Crespo Le\u00f3n","year":"1994"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0080","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1016\/j.vaccine.2015.10.072","article-title":"Phase 1 testing of detoxified LPS\/group B meningococcal outer membrane protein vaccine with and without synthetic CPG 7909 adjuvant for the prevention and treatment of sepsis","volume":"33","author":"Cross","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0085","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1016\/j.vaccine.2009.10.073","article-title":"Evaluation of particulate acellular vaccines against Brucella ovis infection in rams","volume":"28","author":"Da Costa Martins","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0090","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jconrel.2012.07.030","article-title":"Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles","volume":"162","author":"Da Costa Martins","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0095","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1016\/j.vaccine.2007.07.002","article-title":"Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against B. abortus infection in BALB\/c mice","volume":"25","author":"Delpino","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vetimm.2013.04.003","article-title":"Immune response and serum bactericidal activity against Brucella ovis elicited using a short immunization schedule with the polymeric antigen BLSOmp31 in rams","volume":"154","author":"D\u00edaz","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.vetimm.2016.07.004","article-title":"Immune response induced by conjunctival immunization with polymeric antigen BLSOmp31 using a thermoresponsive and mucoadhesive in situ gel as vaccine delivery system for prevention of ovine brucellosis","volume":"178","author":"D\u00edaz","year":"2016","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.msec.2016.01.084","article-title":"Spray dried microspheres based on chitosan: a promising new carrier for intranasal administration of polymeric antigen BLSOmp31 for prevention of ovine brucellosis","volume":"62","author":"D\u00edaz","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.vetimm.2019.02.005","article-title":"Mucosal immunization with polymeric antigen BLSOmp31 using alternative delivery systems against Brucella ovis in rams","volume":"209","author":"D\u00edaz","year":"2019","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0120","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ijpharm.2016.10.065","article-title":"Induction of a balanced Th1\/Th2 immune responses by co-delivery of PLGA\/ovalbumin nanospheres and CpG ODNs\/PEI-SWCNT nanoparticles as TLR9 agonist in BALB\/c mice","volume":"515","author":"Ebrahimian","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1286-4579(02)00075-8","article-title":"The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB\/c mice","volume":"5","author":"Estein","year":"2003","journal-title":"Microbes Infect."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.vetmic.2004.05.004","article-title":"Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis","volume":"102","author":"Estein","year":"2004","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0135","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1016\/j.vaccine.2009.08.097","article-title":"The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams","volume":"27","author":"Estein","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0140","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/jcm.31.8.2141-2145.1993","article-title":"Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis","volume":"31","author":"Goldbaum","year":"1993","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0145","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1099\/00222615-48-9-833","article-title":"The 18-kDa cytoplasmic protein of Brucella spp.\u2014an antigen useful for diagnosis\u2014is a lumazine synthase","volume":"48","author":"Goldbaum","year":"1999","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0150","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/IAI.71.2.857-863.2003","article-title":"Protection of chickens against Escherichia coli infections by DNA containing CpG motifs","volume":"71","author":"Gomis","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41598-018-36588-6","article-title":"Synthetic CpG-ODN rapidly enriches immune compartments in neonatal chicks to induce protective immunity against bacterial infections","volume":"9","author":"Gunawardana","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-4939-3389-1_20","article-title":"Development of CpG ODN based vaccine adjuvant formulations","volume":"1404","author":"Gursel","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0165","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/21645515.2014.1004033","article-title":"CpG oligodeoxynucleotides as mucosal adjuvants","volume":"11","author":"Iho","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0170","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1128\/iai.62.2.632-638.1994","article-title":"Protective immunity to Brucella ovis in BALB\/c mice following recovery from primary infection or immunization with subcellular vaccines","volume":"62","author":"Jimenez de Bagues","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.05.001","article-title":"Vaccine technologies: from whole organisms to rationally designed protein assemblies","volume":"120","author":"Karch","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/1348-0421.12487","article-title":"Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae","volume":"61","author":"Kataoka","year":"2017","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/09712119.2011.565218","article-title":"Effect of CpG oligodeoxynucleotide on the immune response of 28 kDa outer membrane protein of Brucella","volume":"39","author":"Kaushik","year":"2011","journal-title":"J. Appl. An. Res."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0190","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/prot.20248","article-title":"Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides","volume":"57","author":"Laplagne","year":"2004","journal-title":"Proteins"},{"issue":"1","key":"10.1016\/j.rvsc.2021.02.011_bb0195","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1038\/s41598-018-28281-5","article-title":"A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge","volume":"8","author":"Lin","year":"2018","journal-title":"Sci. Rep. 16"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0200","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0034-5288(18)30992-5","article-title":"Comparison of subcutaneous and conjunctival routes of rev 1 vaccination for the prophylaxis of Brucella ovis infection in rams","volume":"48","author":"Mar\u00edn","year":"1990","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1472-6750-11-88","article-title":"Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human toll-like receptor 9 agonists","volume":"11","author":"Meng","year":"2011","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0210","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.anireprosci.2012.01.010","article-title":"Vaccination programs for reproductive disorders of small ruminants","volume":"130","author":"Menzies","year":"2012","journal-title":"Anim. Reprod. Sci."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00915547","article-title":"The common mucosal immune system and current strategies for induction of immune responses in external secretions","volume":"7","author":"Mestecky","year":"1987","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0220","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin. Microbiol. Rev. Apr"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0225","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.vaccine.2005.10.042","article-title":"Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams","volume":"24","author":"Mu\u00f1oz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0230","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/S0264-410X(01)00177-3","article-title":"A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice","volume":"19","author":"Murillo","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0235","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.addr.2008.12.004","article-title":"Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides","volume":"61","author":"Mutwiri","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2004.02.022","article-title":"Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides","volume":"31","author":"Mutwiri","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vetimm.2003.10.001","article-title":"In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep","volume":"98","author":"Nichani","year":"2004","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0250","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1586\/erv.11.110","article-title":"Confronting the barriers to develop novel vaccines against brucellosis","volume":"10","author":"Oliveira","year":"2011","journal-title":"Expert Rev. Vaccines."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0255","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1128\/JVI.73.5.4120-4126.1999","article-title":"CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines","volume":"73","author":"Oxenius","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0260","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2007.09.014","article-title":"Nanostructures form alkyl vitamin C derivatives (ASCn): properties and potential platform for drug delivery","volume":"345","author":"Palma","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0265","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.4049\/jimmunol.0902209","volume":"184","author":"Pasquevich","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0270","article-title":"An oral vaccine based on U-Omp19 induces protection against Brucella abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice","volume":"1","author":"Pasquevich","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0275","series-title":"R Foundation for Statistical Computing","article-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2018"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0280","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.biomaterials.2013.12.002","article-title":"Adjuvant activity of CpG-ODN formulated as a liquid crystal","volume":"35","author":"S\u00e1nchez Vallecillo","year":"2014","journal-title":"Biomaterials."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0285","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2015.07.008","article-title":"A liquid crystal of ascorbyl palmitate, used as vaccine platform, provides sustained release of antigen and has intrinsic pro-inflammatory and adjuvant activities which are dependent on MyD88 adaptor protein. J","volume":"28","author":"S\u00e1nchez Vallecillo","year":"2015","journal-title":"Control Release"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1297-9716-45-61","article-title":"Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection","volume":"45","author":"Sancho","year":"2014","journal-title":"Vet. Res."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0295","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.4049\/jimmunol.1000680","article-title":"Eye mucosa: an efficient vaccine delivery route for inducing protective immunity","volume":"185","author":"Seo","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.02230","article-title":"Characterization of cell envelope multiple mutants of Brucella ovis and assessment in mice of their vaccine potential","author":"Sidhu-Mu\u00f1oz","year":"2018","journal-title":"Front. Microbiol. doi"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0305","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/CVI.00191-15","article-title":"Protection provided by an encapsulated live attenuated \u0394abcBA strain of Brucella ovis against experimental challenge in a murine model","volume":"22","author":"Silva","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"issue":"8","key":"10.1016\/j.rvsc.2021.02.011_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136865","article-title":"Encapsulated Brucella ovis lacking a putative ATP-binding cassette transporter (\u0394abcBA) protects against wild type Brucella ovis in rams","volume":"10","author":"Silva","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0315","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1051\/vetres:2006010","article-title":"The IgA system: a comparison of structure and function in different species","volume":"37","author":"Snoeck","year":"2006","journal-title":"Vet. Res."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0320","first-page":"45","article-title":"Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice","volume":"17","author":"Soler-Llor\u00e9ns","year":"2014","journal-title":"Vet. Res."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0325","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0165-2427(96)05703-0","article-title":"T lymphocyte mediated protection against facultative intracellular bacteria","volume":"54","author":"Splitter","year":"1996","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0330","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1167\/iovs.07-0809","article-title":"Experimental induction and three-dimensional two-photon imaging of conjunctiva-associated lymphoid tissue","volume":"49","author":"Steven","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0335","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.vaccine.2017.11.073","article-title":"Oral administration of PLGA-encapsulated CpG ODN and Campylobacter jejuni lysate reduces cecal colonization by Campylobacter jejuni in chickens","volume":"36","author":"Taha-Abdelaziz","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.rvsc.2021.02.011_bb0340","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.1073\/pnas.0703395104","article-title":"Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody\/Th1 responses and CD8 T cells through cross-priming","volume":"104","author":"Valmori","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0345","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0350","doi-asserted-by":"crossref","first-page":"7020","DOI":"10.1128\/IAI.69.11.7020-7028.2001","article-title":"Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species","volume":"69","author":"Vizca\u00edno","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.rvsc.2021.02.011_bb0355","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1074\/jbc.M312035200","article-title":"High order quaternary arrangement confers increased structural stability to Brucella sp. lumazine synthase","volume":"279","author":"Zylberman","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528821000473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528821000473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T04:23:10Z","timestamp":1758514990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528821000473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":71,"alternative-id":["S0034528821000473"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2021.02.011","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31\/CpG-ODN\/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb\/c mice","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2021.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}